LDL-C

8 drugs in development·6 companies·1 clinical trial

Drug Pipeline by Phase

Approved(8)

Drug	Company
colesevelam	Impax Laboratories, LLC (IPXL)
colestipol	ANI PHARMACEUTICALS INC (ANIP)
fenofibrate	ANI PHARMACEUTICALS INC (ANIP)
fenofibrate	Amneal Pharmaceuticals, Inc. (AMRX)
nexletol	Esperion Therapeutics, Inc. (ESPR)
nexlizet	Esperion Therapeutics, Inc. (ESPR)
pitavastatin	Mylan II B.V. (MYL)
pravastatin	Aptinyx Inc. (APTX)

BioSniper tracks 8 drugs in development for LDL-C across 6 companies.

There are 1 clinical trial targeting LDL-C tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.